🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Wood Uro-Onc Updates...#CGW23 Brian F. Chapin was program chair and did an amazing job collaborating across the UT system to make this happen. Of course this means he has the dubious honor of reading the CME required announcements (oh joy).

Very impressed with the extremely high quality of this quickly assembled conference #CGW23 Those practicing or researching GU oncology would be wise to attend. It definitely honors Chris Wood’s legacy. I’ll be back next year! Brian F. Chapin Neema Navai Tian Zhang, MD, MHS YUO Society of Urologic Oncology

Wonderful evening at the Rodeo Round-Up #CGW23 Great conference with an excellent group of speakers! Sima Porten Brian F. Chapin DrBagrodia Neema Navai Scott Delacroix M.D.

We are pleased to announce that Brittney Cotta @cotta will be joining MD Anderson Cancer Center Dept of Urology this summer as an Assistant Professor of Urology. Dr Cotta will provide care for our oncology patients w/a focus in Kidney Cancer research Kidney Cancer #oncsurgery #endcancer

Listen to our Dr. Neema Navai discuss how we use telehealth to provide personalized care and address the specific needs of our patients: brnw.ch/21wEXm0 HealthTech Magazine Neema Navai #EndCancer

If you dig urology, skiing, and hanging with a group of fun folks in a cozy setting, consider joining us in February for the Aspen Urological Conference. Urologists, APP's, RN's, industry all welcome.

Registrations open. Great venue, Limited rooms. Book soon. Great meeting highlight GU cancer therapies and collaborative research across the UT system

Delighted to be with the #1 Team from ⁦MD Anderson Cancer Center⁩ at ⁦ACHE⁩ Congress. An outstanding group of talented leaders engaged in learning and professional enrichment! Love this team!!

"We concluded based on our 36-month evaluation that nadofaragene was an option for patients who had BCG-unresponsive disease," says our Dr. Colin Dinney of results presented at #EAU24: brnw.ch/21wIFxj #BladderCancer #EndCancer

Valentina Grajales MD, MS Emory Urology Emory Urologic Oncology Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center UPMC Urology So happy for you! I’m sure your dad would be proud. Vikram M. Narayan, MD your mentorship will be impactful. MD Anderson Cancer Center #oncsurgery

Arriving to the Omni Barton Creek for the 2nd annual UT Christopher G Wood Urologic Oncology Symposium Looking forward to discussing clinical care, cutting edge science, clinical trials and collaborative efforts across the UT system MD Anderson Cancer Center #CGW24 #oncsurgery

Michael O’Donnell giving the von Eschenbach Lecture at the 2nd UT Christopher G Wood Urologic Oncology Symposium Many accomplishments; truly a trailblazer, and a dear friend to many in #BladderCancer world MD Anderson Cancer Center #CGW24 #OncSurgery h/t Matt Campbell MD, MS

Neema Navai Kicking off the #CGW24 meeting with Mike O’Donnell, the Von Eschenbach distinguished professor, speaking on intravesical therapies for NMIBC Amazing contributions and an equally amazing lecture MD Anderson Cancer Center

A study led by our Dr. Surena Matin evaluates tolerability and activity of targeted fibroblast growth factor receptor inhibition in localized upper tract urothelial carcinoma. Learn about the findings: brnw.ch/21wJeaM Urology Times Surena F Matin MD #EndCancer

And welcome to out Society of Urologic Oncology MD Anderson Cancer Center class of 2027! #oncsurgery #endcancer

A recent study led by @rondepinho identified a molecule compound that restores physiological levels of telomerase reverse transcriptase (TERT), which is repressed during aging. What this could mean for age-related diseases: bit.ly/4eBaVKU #EndCancer

Help me support IVU - a great organization doing amazing work! runsignup.com/Race/97810/Fun…

Vancouver Prostate Centre Congrats Peter Black Amazing accomplishment!

New findings on MRD detection in urinary DNA 🧬 for #BCGUnresponsive #NMIBC! Using Convergent Genomics UroAmp test, we: • Prognosticate 12-mo RFS post Nadofaragene (Adstiladrin) • Characterize utDNA changes over time David McConkey Côme Tholomier Trevor Levin, PhD euoncology.europeanurology.com/article/S2588-…

Please email [email protected] to link and register for the open house. Kelly Bree Justin R. Gregg, MD Neema Navai John W. Davis, MD Lisly J. Chéry, MD Brittney Cotta, MD Surena F Matin MD Ashish M. Kamat, MD, MBBS 11/14 at 7pm CST Come learn about the Society of Urologic Oncology fellowship program and the many opportunities #oncsurgery